Polypeptides having beta-1,3-galactanase activity and polynucleotides encoding same

US10010094B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10010094-B2
Application numberUS-201414909579-A
CountryUS
Kind codeB2
Filing dateAug 15, 2014
Priority dateAug 15, 2013
Publication dateJul 3, 2018
Grant dateJul 3, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to polypeptides having beta-1,3-galactanase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.

First claim

Opening claim text (preview).

What is claimed is: 1. A method or producing a coffee extract, comprising the steps: (a) providing roast and ground coffee beans; (b) adding water and a polypeptide having beta-1,3-galactanase activity to the coffee beans, wherein the polypeptide has at least 90% sequence identity to the mature polypeptide of SEQ ID NO: 2; (c) incubating to make an aqueous coffee extract; and (d) separating the coffee extract from the extracted coffee beans. 2. The method of claim 1 , wherein the polypeptide has at least 97% sequence identity to the mature polypeptide of SEQ ID NO: 2. 3. The method of claim 1 , wherein the polypeptide is the mature polypeptide of SEQ ID NO: 2. 4. The method of claim 1 , wherein the polypeptide has one or more amino acids absent from the amino and/or carboxyl terminus of the mature polypeptide of SEQ ID NO: 2. 5. The method of claim 1 , wherein the polypeptide is encoded by a polynucleotide having at least 95% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 1. 6. The method of claim 1 , wherein the polypeptide is a variant of the mature polypeptide of SEQ ID NO: 2 comprising a substitution, deletion, and/or insertion at one or more positions.

Assignees

Inventors

Classifications

  • Drying or concentrating coffee extract {(A23F5/246 takes precedence)} · CPC title

  • Galactan endo-beta-1,3-galactanase (3.2.1.181) · CPC title

  • acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81) · CPC title

  • A23F5/246Primary

    Addition of, or treatment with, enzymes or microorganisms (A23F5/163 and A23F5/204 take precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10010094B2 cover?
The present invention relates to polypeptides having beta-1,3-galactanase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Who is the assignee on this patent?
Novozymes As
What technology area does this patent fall under?
Primary CPC classification A23F5/246. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).